Oct 23 (Reuters) - Lumos Pharma Inc ( LUMO ):

* LUMOS PHARMA ENTERS INTO DEFINITIVE MERGER AGREEMENT WITH

DOUBLE

POINT VENTURES TO GO PRIVATE VIA A TENDER OFFER OF $4.25 CASH

PER SHARE PLUS CONTINGENT VALUE RIGHTS (CVR)

* LUMOS PHARMA ENTERS INTO DEFINITIVE MERGER AGREEMENT WITH

DOUBLE

POINT VENTURES TO GO PRIVATE VIA A TENDER OFFER OF $4.25 CASH

PER SHARE PLUS CONTINGENT VALUE RIGHTS (CVR)

* LUMOS PHARMA INC ( LUMO ): PROPOSED DEAL FOR TOTAL EQUITY VALUE OF

APPROXIMATELY $38 MILLION

* LUMOS PHARMA INC ( LUMO ): LUMOS PHARMA WILL CONTINUE AS AN

INDIRECT

WHOLLY-OWNED SUBSIDIARY OF DPV

* LUMOS PHARMA INC ( LUMO ): WITHDRAWS ITS PRIOR CASH RUNWAY GUIDANCE

Source text for Eikon:

Further company coverage: